CAR-T Cell Therapy Shows Promise for Transformed Indolent Non-Hodgkin Lymphoma
A recent retrospective study has shed new light on the effectiveness of chimeric antigen receptor T cell therapy for patients with transformed indolent non-Hodgkin lymphoma